New drugs and perspectives for new anti-tuberculosis regimens S. Tiberi, M. Muñoz-Torrico, R. Duarte, M. Dalcolmo, L. D’Ambrosio, G.-B. Migliori

First clinical evaluation of the QIAreachTM QuantiFERON-TB for tuberculosis infection and active pulmonary disease K. Fukushima, K. Akagi, A. Kondo, T. Kubo, N. Sakamoto, H. Mukae

Managing latent tuberculosis infection and tuberculosis in children I. Carvalho, D. Goletti, S. Manga, D.R. Silva, D. Manissero, G. Migliori